In the wake of a Federal Trade Commission investigation into hospital group Renown Health, following a law firm’s own review of the group’s buyout of a cardiology practice, the Nevada-based business’s CEO and three other executives have resigned. Renown CEO Jim Miller has stepped down from his position after agreeing with the FTC to release 10 cardiologists from the practice the company acquired from non-compete agreements. The group additionally paid $4.2 million to a dozen cardiologists. Renown has acknowledged the antitrust probe as the reason for the CEO’s resignation; a press release from the group’s board chairman noted that “things did not go as planned” concerning the acquisition. He added, “If the execution of the SNCA transaction had been as solid as our intentions, none of this would have occurred.” SCNA, or Sierra Nevada Cardiology Associates, was acquired by Renown in March 2011.
Full Content: Becker’s Hospital Review
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI